Our Promise

CardiaPill® is our lead product.

James D. Otvos, Ph.D.

Founder, Executive Vice President and Chief Scientific Officer, LipoScience Inc.
Dr. Otvos is a founder of LipoScience and has served as Chief Scientific Officer and a director since inception. He has also served as Executive Vice President since 1999.

Read More

David Bell, M.D.

Professor of Medicine at the University of Alabama at Birmingham, School of Medicine
Dr. Bell is a leading authority on the prevention and treatment of type 2 diabetes. During his distinguished career, he has contributed more than 180 articles to the medical literature. He is an active researcher and has served as Director of the Endocrine Clinical Research Program at the University of Alabama Birmingham.

Read More

Carlos M. Ferrario, MD, FACA, FACC

Professor of Physiology and Pharmacology
Director, Hypertension and Vascular Research Center, Wake Forest University, Winston-Salem, NC, USA

Dr. Carlos M. Ferrario graduated from the University of Buenos Aires Medical School in 1963. After his postgraduate training in cardiology at the University of Geteborg and the Karolinska Institute in Sweden, he joined the Cleveland Clinic Foundation in 1966.

Read More